Trading Summary
- Ticker: Longeveron Inc. (LGVN)
- Last close: USD 1.60
- Price change (24 h): +0.63 %
- Trade volume (last 24 h): USD 103 000
- Shares outstanding: 3.2 million
- Market capitalization: USD 5.1 million
Longeveron’s stock closed higher by 0.63 % on Monday, 26 November 2026, at 08:48 AM Central Europe time. The share price is currently approximately USD 1.60 on major exchanges. In the past 24 hours, the company’s shares have traded a total value of about USD 103 000.
Since the end of the previous month, Longeveron’s share price has declined by 45.02 %. The simple moving average over the past 200 days is USD 6.74. The highest price recorded in the last 52 weeks was USD 12.30 on 4 July 2026, while the lowest price in the same period was USD 1.31 on 19 October 2026.
Related Stock Performance (Last 24 h)
| Ticker | Change | Current Price | Market Capitalization |
|---|---|---|---|
| AIRE (Realpha Tech) | +23.88 % | USD 0.99 | USD 5.8 million |
| ACXP (Acurx) | –0.44 % | USD 1.14 | USD 6.0 million |
| TNON (Tenon Medical) | –1.79 % | USD 2.20 | USD 5.9 million |
| SNTI (Senti Biosciences I) | –1.57 % | USD 0.19 | USD 5.9 million |
| PAIN.V (Vector Science And Therapeut) | –3.12 % | CAD 1.55 | CAD 8.5 million |
Company Overview
Longeveron Inc. is a clinical‑stage biotechnology company headquartered in Miami, Florida, United States. The firm focuses on cellular therapies aimed at treating aging‑related and other serious conditions. Longeveron operates on a global scale and markets its products worldwide. Additional information about the company’s research, product pipeline, and investment opportunities can be found on its website at www.longeveron.com or through Nasdaq trading platforms.
